Literature DB >> 8821536

Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.

K E Norman1, T J Williams, M Feldmann, A G Rossi.   

Abstract

1. In this study, the effects of a protein synthesis inhibitor, cycloheximide, and a soluble tumour necrosis factor (TNF) binding/IgG fusion protein, p55-sf2, on the priming and challenge stages of the local Shwartzman reaction (LSR) were assessed and compared with their effects on the acute inflammatory response induced by recombinant human tumour necrosis factor-alpha (rhTNF), lipopolysaccharide (LPS) and a reversed passive Arthus (RPA) reaction in rabbit skin. 2. The LSR was induced in skin by giving an intradermal (i.d.) priming injection of LPS followed by two i.v. challenge injections 20 h and 22 h later. Accumulation of 51-Cr-labelled red blood cells and [125I]-albumin were measured at 24 h as markers of haemorrhage and oedema formation, respectively. 3. The RPA reaction was induced in the rabbit by giving i.d. injections of Arthus anti-serum (anti-bovine-gamma-globulin, BGG) followed 5 min later by an i.v. injection of the antigen (BGG). Oedema formation and the accumulation of 111In-labelled neutrophils produced in the RPA reaction and in response to i.d. injection of rhTNF and LPS were measured over the 4 h period after inducing the responses. 4. A single local injection of cycloheximide (10 micrograms/site) did not inhibit neutrophil accumulation or oedema formation produced by 100% Arthus anti-sera. Although LPS injected i.d. induced a marked dose-dependent neutrophil accumulation, there was little associated plasma leakage. Cycloheximide (10 micrograms/site) did not significantly inhibit the neutrophil accumulation induced by LPS (0.1 microgram/site). In the LSR, priming i.d. injections of LPS caused a dose-dependent increase in haemorrhage and plasma leakage at skin sites after challenge with LPS (two injections of 100 micrograms, i.v.). Co-injection of a single dose of cycloheximide (10 micrograms/site) with LPS (30 micrograms/site) caused a marked reduction in the amount of haemorrhage. Local cycloheximide (10 micrograms/site) administered immediately before LSR challenge did not affect the responses produced in the LSR. 5. Neutrophil accumulation induced by TNF (0.17 micrograms/site) was abolished by co-administration of p55-sf2 (3 micrograms/site) whereas neutrophil accumulation induced by i.d. LPS and produced in the RPA reaction was not affected. In the LSR, haemorrhage and oedema formation were inhibited by p55-sf2 (3 micrograms/site) when it was administered i.d. with the LPS priming injection, but not when given i.d. immediately before LSR challenge. 6. These data suggest that the acute neutrophil accumulation produced in the RPA reaction and in response to i.d. LPS may not be dependent on local protein synthesis or TNF production. On the other hand, haemorrhage appears to be dependent on local protein synthesis during the priming phase but not during the challenge stage of the LSR. Importantly, haemorrhage and plasma leakage appear to be dependent on local TNF generation during the priming phase but not during the challenge stage of the LSR. Thus TNF appears to play a key role in the LSR in rabbit skin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821536      PMCID: PMC1909294          DOI: 10.1111/j.1476-5381.1996.tb15214.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

1.  A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Authors:  T Kohno; M T Brewer; S L Baker; P E Schwartz; M W King; K K Hale; C H Squires; R C Thompson; J L Vannice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.

Authors:  J S Warren; K R Yabroff; D G Remick; S L Kunkel; S W Chensue; R G Kunkel; K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 3.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

4.  The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.

Authors:  A G Rossi; K E Norman; D Donigi-Gale; T S Shoupe; R Edwards; T J Williams
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

5.  Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality.

Authors:  W Lesslauer; H Tabuchi; R Gentz; M Brockhaus; E J Schlaeger; G Grau; P F Piguet; P Pointaire; P Vassalli; H Loetscher
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

Review 6.  Shwartzman reaction.

Authors:  J P Brozna
Journal:  Semin Thromb Hemost       Date:  1990-10       Impact factor: 4.180

7.  Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited.

Authors:  L W Argenbright; R W Barton
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

8.  Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury.

Authors:  H Z Movat; C E Burrowes; M I Cybulsky; C A Dinarello
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

9.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.

Authors:  T H Pohlman; K A Stanness; P G Beatty; H D Ochs; J M Harlan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist.

Authors:  C von Uexküll; S Nourshargh; T J Williams
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

View more
  1 in total

1.  Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis.

Authors:  R S Al-Lamki; W Lu; P Manalo; J Wang; A Y Warren; A M Tolkovsky; J S Pober; J R Bradley
Journal:  Cell Death Dis       Date:  2016-06-30       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.